Izotropic Missed Consensus Estimates

Izotropic (IZOZF) reported a loss of $0.01 per share on revenue of $0.00 million for the fiscal first quarter ended July 2026. The consensus earnings estimate was $0.01 per share. The company missed consensus estimates by 200.00%.

Izotropic Corporation is a medical device company commercializing imaging-based products for the more accurate screening, diagnoses and treatment of breast cancers. Izotropic Corporation is based in NEW YORK.